[email protected]

国际中医药研究

International Research in Chinese Medicine

您当前位置:首页 > 精选文章

International Research in Chinese Medicine. 2022; 2: (2) ; 10.12208/j.ircm.20220044 .

Clinical effect of Huangqi Decoction on acute exacerbation of chronic obstructive pulmonary disease
黄芪汤加减治疗慢性阻塞性肺疾病急性加重期的临床疗效观察

作者: 张红霞 *

高青县黑里寨中心卫生院 山东淄博

*通讯作者: 张红霞,单位:高青县黑里寨中心卫生院 山东淄博;

收录截图(CNKI-Scholar)

引用本文: 张红霞 黄芪汤加减治疗慢性阻塞性肺疾病急性加重期的临床疗效观察[J]. 国际中医药研究, 2022; 2: (2) : 103-105.
Published: 2022/8/25 17:56:24

摘要

目的 探讨在慢阻肺急性加重期治疗中以中药黄芪汤实施加减治疗的干预价值。方法 试验者是2020年1月至2022年5月在医院治疗的急性加重期慢阻肺病患数量共计80例,采取随机信封法均分2组,对照组采用常规西医疗法,观察组采用中药黄芪汤加减疗法,比对组间施治效果及肺功能指标差异性。结果 观察组病患施治后总有效率比对照组病患高,观察组病患第一秒用力呼气量、用力肺活量及第一秒用力呼气量占用力肺活量的百分比各项肺功能指标高于对照组病患,P<0.05。结论 以中药黄芪汤加减疗法施治,利于控制病患病情发展,缓解临床症状,同时还能对其肺功能进行有效改善,对促进疾病恢复起着积极意义,适宜基层医院借鉴应用。

关键词: 急性加重期;慢阻肺;黄芪汤;疗效;肺功能

Abstract

Objective To explore the intervention value of Huangqi Decoction in the treatment of acute exacerbation of chronic obstructive pulmonary disease (COPD).
Methods the subjects were 80 patients with COPD in acute exacerbation period treated in the hospital from January 2020 to may 2022. They were randomly divided into two groups. The control group was treated with conventional western medicine, and the observation group was treated with the addition and subtraction of Huangqi decoction. The treatment effects and pulmonary function indexes between the groups were compared.
Results the total effective rate in the observation group was higher than that in the control group. The first second forced expiratory volume, forced vital capacity and the percentage of the first second forced expiratory volume in forced vital capacity in the observation group were higher than those in the control group (P < 0.05).
Conclusion   the treatment of Huangqi decoction is beneficial to control the development of patients' condition, alleviate clinical symptoms, and effectively improve their lung function. It plays a positive role in promoting disease recovery, and is suitable for reference in grass-roots hospitals.

Key words: Acute exacerbation period; COPD; Huangqi Decoction; Curative effect; Pulmonary function

参考文献 References

[1] 朱秋秋,卢波强,杨惠琴. 慢性阻塞性肺疾病急性加重期的中医治疗进展[J]. 新疆中医药,2022,40(02):107-109.

[2] 李伟. 黄芪汤治疗急性加重期慢性阻塞性肺疾病临床观察[J]. 光明中医,2022,37(06):955-957.

[3] 陆宇. 黄芪汤加减治疗急性加重期慢性阻塞性肺疾病的疗效分析[J]. 中医临床研究,2021,13(30):13-15.

[4] 任英杰,王起,陈秋生. 黄芪汤加减治疗急性加重期慢性阻塞性肺疾病疗效研究[J]. 陕西中医,2020,41(01):57-59.

[5] 张启发,范丽霞,刘寨东. 黄芪汤化裁联合常规疗法治疗慢性阻塞性肺疾病急性加重期气虚血瘀证40例临床研究[J]. 江苏中医药,2019,51(07):27-30.

[6] 马丽亚, 高智星, 董晶晶,等. 黄芪汤加减治疗气虚痰瘀型慢性阻塞性肺疾病的疗效[J]. 中华临床医师杂志:电子版, 2019, 13(10):4.

[7] 郑惠之, 黄梅. 加味黄芪汤结合西医常规疗法治疗慢性阻塞性肺疾病急性加重期临床研究[J]. 国际中医中药杂志, 2019, 41(1):5.

[8] 张启发, 范丽霞, 刘寨东. 黄芪汤化裁联合常规疗法治疗慢性阻塞性肺疾病急性加重期气虚血瘀证40例临床研究[J]. 江苏中医药, 2019, 51(7):4.

[9] 李宏,宋大彬. 加减补肺汤治疗慢性阻塞性肺病稳定期肺脾肾虚证临床观察[J]. 医药前沿, 2016, 6(020):288-289.

[10] 马玉玲. 慢性阻塞性肺疾病缓解期中医辨证论治的文献研究[D]. 暨南大学, 2015.

[11] 郦岳, 王益斐, 张赟华,等. 黄芪建中汤合经皮穴位电刺激治疗脾肺虚寒证慢性阻塞性肺病行机械通气87例[J]. 浙江中医杂志, 2017, 52(4):1.

[12] 王益斐, 周杨, 马黄钢, et al. 基于"脾胃论"内外合治辅助慢性阻塞性肺疾病患者机械通气撤离对患者预后的影响研究[J]. 中国全科医学, 2019, 22(12):7.

[13] 陆炜青. 申春悌治疗肺系疾病经验传薪及慢性支管炎中医"临界辨证"方法一致性临床研究[D]. 南京中医药大学, 2015.

[14] 徐升, 魏姗姗, 张念志,等. 黄芪建中汤对慢性阻塞性肺疾病稳定期大鼠呼吸肌疲劳影响的实验研究[J]. 2022(5).

[15] 韩旭东. 桑白皮汤联合西药治疗痰热郁肺型慢性阻塞性肺病随机平行对照研究[J]. 实用中医内科杂志,2015(2):2.